Sign in
Not yet taking people in United StatesNo phase

Clinician Practice Companion to Address Youth Substance Use

Key facts

Who runs it
Massachusetts General Hospital
Where
Boston, United StatesSee the siteAlso in 1 other country, 4 sites
Trial code
Status
Not yet recruiting
People taking part
60 people, planned
Starts
Jan 2027
Expected to end
Dec 2029
Type of study
Interventional
Treatments tested
  • Practice Companion
Record updated
7 October 2026

Who can take part

Age
14 years to 24 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Ages 14 to 24 years
  • Uses drugs or alcohol (past year)
  • Receiving care at a participating study site

Who cannot take part

  • Any medical or psychiatric condition causing acute distress or requiring emergency evaluation
  • Cognitive limitations or intellectual disabilities that prevent provision of informed consent
  • Current membership on a study Community Advisory Board

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 14 and 24 years old?

Where in United States

Also in 1 other country, 4 sites

  • Adolescent and Young Adult Medicine, Mass General Brigham for ChildrenBoston, United StatesContact: Danya Fast, PhDNot yet recruiting

About the trial

What the trial wants to find out

Substance use, including the use of opioids, cannabis, and other drugs, is common among adolescents and young adults, and overdose has become a leading cause of death among youth in Canada and the United States. Many young people who use substances also experience co-occurring mental health concerns. Evidence-based approaches to youth substance use care exist, including overdose prevention and safety strategies (such as naloxone) and medications for addiction treatment. These approaches remain adult-oriented, however, unevenly implemented in youth-serving settings, and insufficiently centered on the needs and goals of youth and their families.

Read full original descriptionShow less

This study develops and pilot tests a written "practice companion" that helps clinicians and other trusted adults provide developmentally appropriate substance use care to youth ages 14 to 24 in hospital and community settings. The practice companion offers practical, easy-to-use guidance organized by substance and by pattern of use. It addresses cannabis and other substances that youth commonly use and that clinicians frequently seek support with, alongside a strong focus on overdose prevention through its core elements: naloxone, other safety strategies, overdose prevention and safety education, and medications for opioid use disorder. It also attends to co-occurring mental health needs and to how poverty, housing instability, and other social circumstances shape substance use and access to care.

The research team will first interview youth who use substances, their families and caregivers, and clinicians to learn how each element of care should be adapted for young people. The team will then produce the practice companion and pilot test it with 60 youth across three sites, in British Columbia, Québec, and Massachusetts. After receiving care guided by the practice companion, youth will complete an interview about whether the care was relevant, useful, appropriate, and acceptable. Families and clinicians will also be interviewed to assess how feasible, sustainable, and faithful to its design the practice companion is in practice.

Throughout the study, the team will work closely with youth and families who have lived experience through a community-based participatory research approach that includes Community Advisory Boards. Findings will guide a larger future study of the practice companion's effectiveness.

The group in the trial

  • Practice CompanionTreatment being tested

    Youth ages 14 to 24 who use substances receive developmentally appropriate substance use care from a clinician (or other trained provider) using the practice companion. Depending on individual needs, the provider offers guidance across the practice companion's elements, including overdose prevention (naloxone, other safety strategies, overdose prevention and safety education, and medications for addiction treatment), support around cannabis and other substance use, and attention to co-occurring mental health, delivered through non-stigmatizing, youth- and family-centered scripts and referral guidance.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT07725289, who can take part
Record updated
7 October 2026